Exhibit 99.1
Consent of Director Nominee
AXA Equitable Holdings, Inc.
1290 Avenue of the Americas
New York, NY 10104
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on FormS-1 (No.333-221521) (the “Registration Statement”) of AXA Equitable Holdings, Inc. (the “Company”), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, and any amendment to such Registration Statement, and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
[remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned has executed this consent as of 20 April, 2018.
| By: | /s/ Karima Silvent | |
| Name: | Karima Silvent |
[Signature Page to Consent]
Consent of Director Nominee
AXA Equitable Holdings, Inc.
1290 Avenue of the Americas
New York, NY 10104
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on FormS-1 (No.333-221521) (the “Registration Statement”) of AXA Equitable Holdings, Inc. (the “Company”), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, and any amendment to such Registration Statement, and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
[remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned has executed this consent as of 20th April, 2018.
| By: | /s/ Bertrand Poupart-Lafarge | |
| Name: | Bertrand Poupart-Lafarge |
[Signature Page to Consent]
Consent of Director Nominee
AXA Equitable Holdings, Inc.
1290 Avenue of the Americas
New York, NY 10104
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on FormS-1 (No.333-221521) (the “Registration Statement”) of AXA Equitable Holdings, Inc. (the “Company”), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, and any amendment to such Registration Statement, and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
[remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned has executed this consent as of April 20, 2018.
| By: | /s/ Daniel G. Kaye | |
| Name: | Daniel G. Kaye |
[Signature Page to Consent]
Consent of Director Nominee
AXA Equitable Holdings, Inc.
1290 Avenue of the Americas
New York, NY 10104
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on FormS-1 (No.333-221521) (the “Registration Statement”) of AXA Equitable Holdings, Inc. (the “Company”), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, and any amendment to such Registration Statement, and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
[remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned has executed this consent as of April 20, 2018.
| By: | /s/ Ramon de Oliveira | |
| Name: | Ramon de Oliveira |
[Signature Page to Consent]
Consent of Director Nominee
AXA Equitable Holdings, Inc.
1290 Avenue of the Americas
New York, NY 10104
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on FormS-1 (No.333-221521) (the “Registration Statement”) of AXA Equitable Holdings, Inc. (the “Company”), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, and any amendment to such Registration Statement, and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
[remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned has executed this consent as of April 20, 2018.
| By: | /s/ Charles Stonehill | |
| Name: | Charles Stonehill |
[Signature Page to Consent]
